Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 395,885,600
  • Shares Outstanding, K 2,686,520
  • Annual Sales, $ 71,890 M
  • Annual Income, $ 16,540 M
  • 36-Month Beta 0.80
  • Price/Sales 5.45
  • Price/Cash Flow 17.75
  • Price/Book 5.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
138.72 +6.23%
on 01/02/18
148.32 -0.65%
on 01/17/18
+5.58 (+3.94%)
since 12/19/17
3-Month
136.60 +7.88%
on 11/22/17
148.32 -0.65%
on 01/17/18
+5.32 (+3.75%)
since 10/19/17
52-Week
110.76 +33.04%
on 01/25/17
148.32 -0.65%
on 01/17/18
+33.16 (+29.04%)
since 01/19/17

Most Recent Stories

More News
Q4 Earnings Season: Strong Growth, But Weak Quality

Q4 Earnings Season: Strong Growth, But Weak Quality

NFLX : 220.46 (+0.06%)
UAL : 76.50 (+0.26%)
C : 78.30 (+1.18%)
VZ : 51.91 (+0.70%)
HON : 158.69 (+0.58%)
F : 12.00 (-0.58%)
JNJ : 147.36 (+0.30%)
TXN : 116.83 (+0.36%)
MMM : 248.18 (+0.92%)
CMCSA : 42.50 (+1.55%)
SBUX : 61.26 (+0.28%)
IBM : 162.37 (-3.99%)
INTC : 44.82 (+0.76%)
PG : 91.07 (+0.99%)
CAT : 170.41 (+0.94%)
AXP : 98.03 (-1.83%)
GE : 16.26 (-3.04%)
AIG : 61.55 (+0.03%)
Q4 Earnings Season: Strong Growth, But Weak Quality

Q4 Earnings Season: Strong Growth, But Weak Quality

NFLX : 220.46 (+0.06%)
UAL : 76.50 (+0.26%)
C : 78.30 (+1.18%)
VZ : 51.91 (+0.70%)
HON : 158.69 (+0.58%)
F : 12.00 (-0.58%)
JNJ : 147.36 (+0.30%)
TXN : 116.83 (+0.36%)
MMM : 248.18 (+0.92%)
CMCSA : 42.50 (+1.55%)
SBUX : 61.26 (+0.28%)
IBM : 162.37 (-3.99%)
INTC : 44.82 (+0.76%)
PG : 91.07 (+0.99%)
CAT : 170.41 (+0.94%)
AXP : 98.03 (-1.83%)
GE : 16.26 (-3.04%)
AIG : 61.55 (+0.03%)
Upcoming Consumer Earnings Reports to Watch: JNJ, F, SBUX

Fourth-quarter earnings season is finally underway, and investors are already getting excited about the upcoming reports from market-moving tech companies like Netflix (NFLX). Make sure to keep an eye...

NFLX : 220.46 (+0.06%)
SBUX : 61.26 (+0.28%)
F : 12.00 (-0.58%)
JNJ : 147.36 (+0.30%)
Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings?

J&J's (JNJ) pharma segment sales growth accelerated in the third quarter and we are likely to see, a continuation of the positive trend in the fourth quarter.

CELG : 102.65 (+0.91%)
JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
GSK : 38.20 (+0.08%)
The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis

The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis

NVO : 57.79 (+2.27%)
JNJ : 147.36 (+0.30%)
ZTS : 76.62 (+0.38%)
ABBV : 104.64 (+0.80%)
AMGN : 189.28 (+0.90%)
Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah Label Expansion

Focus this week was on Merck's (MRK) data on Keytruda as well as Novartis's updates on Kymriah and its biosimilar efforts.

JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
NVS : 86.94 (+0.61%)
GILD : 80.98 (-0.23%)
PFE : 36.94 (-0.14%)
GSK : 38.20 (+0.08%)
BMY : 62.28 (+0.73%)
Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?

We present four large cap drug companies, which are expected to repeat their last year's industry beating performance in 2018.

NVO : 57.79 (+2.27%)
JNJ : 147.36 (+0.30%)
ZTS : 76.62 (+0.38%)
ABBV : 104.64 (+0.80%)
AMGN : 189.28 (+0.90%)
Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label

Amgen (AMGN) gets an earlier-than-expected approval to include ENDEAVOR study OS data on Kyprolis label.

CELG : 102.65 (+0.91%)
JNJ : 147.36 (+0.30%)
VRTX : 157.97 (+0.50%)
AMGN : 189.28 (+0.90%)
Market at New Highs: Mega Cap ETFs & Stocks On A Roll

Inside mega cap ETFs & stocks hitting all-time highs with the skyrocketing market.

XLG : 199.89 (+0.16%)
JNJ : 147.36 (+0.30%)
BRK.B : 213.25 (+0.03%)
MGC : 96.61 (+0.37%)
DIA : 260.54 (+0.15%)
BA : 337.73 (-0.71%)
WMT : 104.59 (+0.28%)
J&J (JNJ) Hits New 52-Week High: What's Driving the Stock?

Promising data from several pivotal studies and a rapid pipeline progress contribute to a rally in Johnson & Johnson's (JNJ) shares.

CELG : 102.65 (+0.91%)
JNJ : 147.36 (+0.30%)
ABBV : 104.64 (+0.80%)
GSK : 38.20 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 148.37
1st Resistance Point 147.87
Last Price 147.36
1st Support Level 146.64
2nd Support Level 145.91

See More

52-Week High 148.32
Last Price 147.36
Fibonacci 61.8% 133.97
Fibonacci 50% 129.54
Fibonacci 38.2% 125.11
52-Week Low 110.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.